import type { Metadata } from 'next';
import Link from 'next/link';
import { GlpAlternativesTable } from '@/components/guides/GlpAlternativesTable';
import { AuthorByline } from '@/components/shared/AuthorByline';
import { TrustBlock } from '@/components/library/TrustBlock';
import { buildBreadcrumbSchema, buildFAQPageSchema, buildLibraryMedicalWebPageSchema } from '@/lib/seo/schema';
import { LAST_REVIEWED_DATE } from '@/data/constants';
import { SchemaInjector } from '@/components/schema-injector';
import { ArrowRight, Info, ShieldAlert } from 'lucide-react';

const CANONICAL = 'https://peptidex.app/guides/glp1-alternatives';

export const metadata: Metadata = {
  title: 'GLP-1 Alternatives: 10 Peptides for Weight Loss in 2026',
  description: 'Looking for Semaglutide or Tirzepatide alternatives? Compare 10 peptides for weight loss including Retatrutide, Tesofensine, AOD-9604, and MOTS-c.',
  alternates: { canonical: CANONICAL },
  openGraph: {
    title: 'GLP-1 Alternatives: 10 Peptides for Weight Loss in 2026',
    description: 'Looking for Semaglutide or Tirzepatide alternatives? Compare 10 peptides for weight loss.',
    url: CANONICAL,
    type: 'article'
  }
};

export default function GlpAlternativesPage() {
  const breadcrumbSchema = buildBreadcrumbSchema([
    { name: 'Home', url: 'https://peptidex.app' },
    { name: 'Guides', url: 'https://peptidex.app/guides' },
    { name: 'GLP-1 Alternatives', url: CANONICAL }
  ]);

  const faqSchema = buildFAQPageSchema([
    { q: 'What is the best alternative to Semaglutide?', a: 'Tirzepatide is currently the most effective FDA-approved alternative, while Retatrutide (in Phase 3 trials) shows even greater weight loss potential. Non-GLP-1 alternatives include Tesofensine and AOD-9604.' },
    { q: 'Are there oral GLP-1 alternatives?', a: 'Yes, Rybelsus is an oral semaglutide. For non-GLP-1 oral alternatives, 5-Amino-1MQ and Tesofensine are administered orally in research settings.' },
    { q: 'How does Retatrutide compare to Tirzepatide?', a: 'Retatrutide is a tri-agonist (GLP-1/GIP/Glucagon) whereas Tirzepatide is a dual-agonist (GLP-1/GIP). Clinical trials indicate Retatrutide yields approximately 24% weight loss vs Tirzepatide\'s 20%.' },
    { q: 'Can you stack AOD-9604 with GLP-1s?', a: 'In research protocols, AOD-9604 is sometimes stacked with GLP-1s to specifically target lipolysis without further suppressing appetite. However, this is experimental.' },
    { q: 'Is Tesofensine a peptide?', a: 'No, Tesofensine is a small molecule monoamine reuptake inhibitor, not a peptide. It is often grouped with peptide weight loss research due to its profound metabolic effects.' }
  ]);

  const medicalWebPageSchema = buildLibraryMedicalWebPageSchema({
    name: 'GLP-1 Alternatives: 10 Peptides for Weight Loss',
    description: 'A comprehensive review of 10 peptide and small-molecule alternatives to GLP-1 agonists for weight loss and metabolic research.',
    url: CANONICAL,
    datePublished: '2026-05-07',
    dateModified: '2026-05-07',
    reviewedBy: { name: 'Dr. E. Vance, PhD', url: 'https://peptidex.app/team/peptidex-research' },
    about: { '@type': 'MedicalCondition', name: 'Obesity' },
    keywords: ['GLP-1 alternatives', 'weight loss peptides', 'semaglutide alternative', 'tirzepatide alternative', 'retatrutide']
  });

  const allSchemas: Record<string, unknown>[] = [breadcrumbSchema, medicalWebPageSchema];
  if (faqSchema) allSchemas.push(faqSchema);

  return (
    <main id="main-content">
      <SchemaInjector schema={allSchemas} />

      <header className="page-header">
        <div className="page-header-grid" />
        <div className="page-header-wrap">
          <nav className="breadcrumb">
            <Link href="/">Home</Link>
            <span className="sep">/</span>
            <Link href="/guides">Guides</Link>
            <span className="sep">/</span>
            <span className="current">GLP-1 Alternatives</span>
          </nav>
          
          <div className="section-label">§ Clinical Guide</div>
          <h1 className="page-title">
            GLP-1 Alternatives: <br /><em>10 Peptides for Weight Loss</em>.
          </h1>
          <p className="page-subtitle">Beyond Semaglutide: A comprehensive guide to next-generation incretins, fat-targeting fragments, and metabolic regulators.</p>
          
          <div className="mt-6">
            <AuthorByline name="Dr. E. Vance" date={LAST_REVIEWED_DATE} variant="compact" />
          </div>
        </div>
      </header>

      <div className="about-content fade-up space-y-16">
        <div className="bg-zinc-900 border-l-4 border-violet-500 p-6 rounded-r-xl mb-12">
          <h2 className="text-lg font-bold text-white mb-2">Quick Answer</h2>
          <p className="text-zinc-300">
            The best <strong>GLP-1 alternatives</strong> fall into two categories: next-generation incretins (like <Link href="/library/tirzepatide" className="text-violet-400 hover:underline">Tirzepatide</Link> and <Link href="/library/retatrutide" className="text-violet-400 hover:underline">Retatrutide</Link>) which offer superior weight loss (~20-24%) by targeting multiple receptors, and non-incretin metabolic regulators (like <Link href="/library/tesofensine" className="text-violet-400 hover:underline">Tesofensine</Link>, <Link href="/library/aod-9604" className="text-violet-400 hover:underline">AOD-9604</Link>, and <Link href="/library/mots-c" className="text-violet-400 hover:underline">MOTS-c</Link>) which boost fat burning without the severe appetite suppression or gastrointestinal side effects associated with Semaglutide.
          </p>
        </div>

        <article className="prose prose-invert prose-violet max-w-none">
          <h2>Why Seek GLP-1 Alternatives?</h2>
          <p>
            While GLP-1 receptor agonists (like Semaglutide/Ozempic) have revolutionized obesity treatment, they are not a silver bullet. Researchers and patients seek alternatives for four primary reasons:
          </p>
          <ul>
            <li><strong>Side Effects:</strong> Nausea, gastroparesis, and severe GI distress force many to discontinue use.</li>
            <li><strong>Muscle Loss:</strong> Rapid weight loss on GLP-1s often includes significant lean muscle wasting if protein intake and resistance training are not optimized.</li>
            <li><strong>The "Plateau":</strong> Many users hit a weight loss plateau after 6-12 months as the body adapts to the GLP-1 receptor stimulation.</li>
            <li><strong>Cost & Shortages:</strong> Unprecedented demand has led to global shortages and exorbitant prices for branded pens.</li>
          </ul>

          <h2>The 10 Best Peptides for Weight Loss</h2>
          
          <GlpAlternativesTable />

          <hr className="my-12 border-zinc-800" />

          <h3>1. Tirzepatide (Mounjaro® / Zepbound®)</h3>
          <p>
            Tirzepatide is a dual-agonist targeting both GLP-1 and GIP receptors. It is currently the most effective FDA-approved weight loss medication on the market.
          </p>
          <ul>
            <li><strong>Mechanism:</strong> The addition of GIP improves tolerability and significantly enhances fat metabolism compared to GLP-1 alone.</li>
            <li><strong>Weight Loss:</strong> Clinical trials show ~20% body weight loss.</li>
          </ul>
          <div className="flex gap-4 not-prose mb-12">
            <Link href="/library/tirzepatide" className="text-sm font-bold text-violet-400 hover:text-violet-300">Read Tirzepatide Profile →</Link>
            <Link href="/where-to-buy/tirzepatide" className="text-sm font-bold text-amber-400 hover:text-amber-300">Where to Buy →</Link>
          </div>

          <h3>2. Retatrutide (LY3437943)</h3>
          <p>
            Retatrutide is the next evolution in incretin therapy—a tri-agonist targeting GLP-1, GIP, and Glucagon (GCGR) receptors. 
          </p>
          <ul>
            <li><strong>Mechanism:</strong> The addition of the Glucagon receptor actively increases basal metabolic rate and liver fat clearance.</li>
            <li><strong>Weight Loss:</strong> Phase 2 trials demonstrated an unprecedented 24.2% weight loss at 48 weeks.</li>
          </ul>
          <div className="flex gap-4 not-prose mb-12">
            <Link href="/library/retatrutide" className="text-sm font-bold text-violet-400 hover:text-violet-300">Read Retatrutide Profile →</Link>
            <Link href="/where-to-buy/retatrutide" className="text-sm font-bold text-amber-400 hover:text-amber-300">Where to Buy →</Link>
          </div>

          <h3>3. Tesofensine</h3>
          <p>
            Tesofensine is not a peptide; it is a serotonin-noradrenaline-dopamine reuptake inhibitor (SNDRI). Originally developed for neurodegenerative diseases, it was repurposed due to profound weight loss side effects.
          </p>
          <ul>
            <li><strong>Mechanism:</strong> Suppresses appetite centrally while actively increasing resting energy expenditure (thermogenesis).</li>
            <li><strong>Weight Loss:</strong> ~10-12% over 6 months in trials. Administered orally.</li>
          </ul>
          <div className="flex gap-4 not-prose mb-12">
            <Link href="/library/tesofensine" className="text-sm font-bold text-violet-400 hover:text-violet-300">Read Tesofensine Profile →</Link>
          </div>

          <h3>4. AOD-9604</h3>
          <p>
            AOD-9604 is a synthetic fragment of Human Growth Hormone (amino acids 177-191). It was designed to retain the fat-burning properties of HGH without affecting blood sugar or tissue growth.
          </p>
          <ul>
            <li><strong>Mechanism:</strong> Stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat storage).</li>
            <li><strong>Weight Loss:</strong> Modest, but highly specific to fat mass. Often used by athletes cutting weight to preserve muscle.</li>
          </ul>
          <div className="flex gap-4 not-prose mb-12">
            <Link href="/library/aod-9604" className="text-sm font-bold text-violet-400 hover:text-violet-300">Read AOD-9604 Profile →</Link>
          </div>

          <h3>5. MOTS-c</h3>
          <p>
            A mitochondrial-derived peptide that regulates metabolic homeostasis. It is often referred to as an "exercise mimetic."
          </p>
          <ul>
            <li><strong>Mechanism:</strong> Activates AMPK, increasing cellular energy expenditure and improving insulin sensitivity.</li>
            <li><strong>Weight Loss:</strong> Mild, but significantly improves exercise capacity and metabolic flexibility.</li>
          </ul>
          <div className="flex gap-4 not-prose mb-12">
            <Link href="/library/mots-c" className="text-sm font-bold text-violet-400 hover:text-violet-300">Read MOTS-c Profile →</Link>
            <Link href="/where-to-buy/mots-c" className="text-sm font-bold text-amber-400 hover:text-amber-300">Where to Buy →</Link>
          </div>

          <hr className="my-12 border-zinc-800" />

          <h2>How to Choose: A Decision Framework</h2>
          <p>Selecting an alternative depends on your primary roadblock to weight loss:</p>
          <ul>
            <li><strong>If you need maximum appetite suppression:</strong> Tirzepatide or Retatrutide.</li>
            <li><strong>If you struggle with fatigue and slow metabolism:</strong> Tesofensine (increases energy) or MOTS-c (improves cellular energy).</li>
            <li><strong>If you want to preserve muscle while cutting:</strong> AOD-9604 or Tesamorelin (targets visceral fat while raising natural GH).</li>
            <li><strong>If you cannot tolerate injections:</strong> Tesofensine or 5-Amino-1MQ (both oral).</li>
          </ul>

          <div className="bg-amber-500/10 border border-amber-500/20 p-6 rounded-xl my-8">
            <h3 className="text-amber-400 font-bold flex items-center gap-2 mt-0 mb-2">
              <ShieldAlert className="w-5 h-5" /> Safety and Sourcing
            </h3>
            <p className="text-zinc-300 text-sm m-0">
              Many of the compounds on this list (like Retatrutide and Tesofensine) are strictly in the clinical trial phase and are not FDA-approved for human use. They are available only as research chemicals. If you are conducting in-vitro research, ensure you are sourcing from vendors that provide 3rd-party HPLC Certificates of Analysis. 
            </p>
            <Link href="/where-to-buy" className="inline-flex items-center gap-2 text-amber-400 hover:text-amber-300 font-bold text-sm mt-4">
              View our directory of COA-Verified Vendors <ArrowRight className="w-4 h-4" />
            </Link>
          </div>

          <h2>Frequently Asked Questions</h2>
          <h4 className="font-bold text-zinc-100">What is the best alternative to Semaglutide?</h4>
          <p>Tirzepatide is currently the most effective FDA-approved alternative, while Retatrutide shows even greater weight loss potential in Phase 3 trials. Non-GLP-1 alternatives include Tesofensine and AOD-9604.</p>

          <h4 className="font-bold text-zinc-100">Are there oral GLP-1 alternatives?</h4>
          <p>Yes, Rybelsus is an oral semaglutide. For non-GLP-1 oral alternatives, 5-Amino-1MQ and Tesofensine are administered orally in research settings.</p>

          <h4 className="font-bold text-zinc-100">Can you stack AOD-9604 with GLP-1s?</h4>
          <p>In research protocols, AOD-9604 is sometimes stacked with GLP-1s to specifically target lipolysis without further suppressing appetite, attempting to mitigate muscle loss. However, this is experimental.</p>

        </article>

        <TrustBlock />
      </div>
    </main>
  );
}
